The Pulse of ACC | Call For Applications for CardioSmart Editor; ACC and Butterfly Join Forces; More

Call For Applications for CardioSmart Editor; ACC and Butterfly Join Forces; More

Mark Your Calendar: ACC.21 Key Dates

Planning for ACC.21 in Atlanta in May 2021 is moving ahead, with registration and call for abstracts kicking off this month.

The ACC.21 abstract submission process opened on Oct. 7. Clinicians are encouraged to submit science across 10 learning pathways PLUS the Spotlight on Special Topics, Complex Clinical Cases (including FIT Cases, CVT Cases and MD/PhD Cases), and Interventional Challenging Cases. The deadline for submissions is Dec. 2. Young Investigator Award submissions continue to be accepted through Oct. 27.


"Late-breaking science is a hallmark component of every ACC Annual Scientific Session and ACC.21 will be no different," says ACC.21 Vice Chair Douglas Drachman, MD, FACC. "We are looking forward to showcasing the latest in practice-changing clinical research and facilitating critical discussion and debate."

In addition to abstract submissions, Early Bird registration opens Wednesday, Oct. 28 for members and Thursday, Nov. 12 for nonmembers. Attendees can choose from new Gold, Silver or Bronze registration packages, designed to meet a variety of individual needs.

"ACC.21 will provide a much-needed opportunity for the cardiovascular community to come together to navigate emerging science, learn from expert faculty and each other, and more importantly reengage and reconnect with colleagues from around the globe," says ACC Annual Scientific Session Chair Pamela B. Morris, MD, FACC.

Morris adds that attendees can have confidence that ACC.21 is being planned based on the latest CDC guidelines to ensure a healthy and safe environment including the required use of masks, social distancing, smaller capacity meeting rooms, and additional spacing throughout the Georgia World Congress Center. For those unable to join live in Atlanta, ACC.21 Virtual will provide an innovative digital platform for learning, collaboration and networking at times that work best for individual schedules.

"While the past six months have brought with them profound change for clinicians and patients alike, the need for education, innovation and new science to help us optimize cardiovascular care and improve outcomes remains constant," says ACC President Athena Poppas, MD, FACC. "ACC.21 promises to deliver in all of these areas."

Learn more at


ACC and Butterfly Network Join Forces to Transform CV Care With Ultrasound

The ACC and Butterfly Network are joining forces to transform the use of ultrasound within cardiology using a next-generation ultrasound product, Butterfly iQ+ – the world's only single-probe, whole-body ultrasound system that connects to a mobile device and features an integrated telemedicine platform.


"Our collaboration with the ACC will help us design clinical trials and care pathways for some of the more challenging heart diseases and accelerate the adoption of point-of-care ultrasound by cardiovascular clinicians," says John Martin, MD, Butterfly Network's Chief Medical Officer.

"One of the key targets is heart failure, with a goal to radically change monitoring. If patients can assess their status at home via AI-guided lung scans with their clinician or care team remotely, we can avoid unnecessary and costly hospital visits. This will also provide patients with more timely intervention, improve quality of care, and improve their quality of life."

Butterfly Network has long recognized that the key to unlocking the value of ultrasound is to remove the barriers of cost and complexity in traditional systems through innovation. ACC's strategic investment in Butterfly Network and collaboration on clinical trials will increase access to point-of-care ultrasound in the management of critical cardiovascular diseases.

"Through innovative collaborations like this – directly linking the technology and clinical worlds – the ACC aims to transform cardiovascular care and improve health outcomes," says John S. Rumsfeld, MD, PhD, FACC, ACC's Chief Science and Chief Innovation Officer.

"The ACC will work in sync with Butterfly to help guide the scientific evaluation and clinical integration of point-of-care ultrasound in the management of cardiovascular conditions."


Call For Applications: CardioSmart Associate Editor

The ACC is now accepting applications for the next ACC CardioSmart Associate Editor. The new editor's term will begin July 2021 and end July 2024, with the possibility of re-appointment for an additional three-year term. The deadline for applications is Friday, Nov. 13.

The CardioSmart associate editor will be primarily responsible for advising and ensuring clinical accuracy of the editorial content development on the website, including the development of CardioSmart news and information. The associate editor will assist in developing innovative strategies to help the College best engage, educate and activate patients in their care.

In addition, the associate editor will serve as an ex officio member of the Solution Set Oversight Committee.

Clinical Topics: COVID-19 Hub, Heart Failure and Cardiomyopathies, Acute Heart Failure

Keywords: ACC Publications, Cardiology Magazine, Heart Failure, Myocarditis, Point-of-Care Systems, Quality of Life, Prevalence, African Americans, Cardiovascular Diseases, COVID-19, Goals, Standard of Care, Stroke Volume, severe acute respiratory syndrome coronavirus 2, Hispanic Americans

< Back to Listings